FDA approves expanded use of Mirum's liver disease drug

The U.S Food and Drug Administration has approved the expanded use of Mirum Pharmaceuticals' (MIRM.O) oral drug to treat itching caused by a liver disorder in patients aged five years and older, the company said on Wednesday.